menu search

Chiral chromatography columns market size worth usd 104.34 million by 2030 at 4.20% cagr – report by market research future (mrfr)

Chiral Chromatography Columns Market Trends and Insights by Material (Metal-Based Columns, Glass-Based Columns and Plastic-Based Columns), by Product ...

January 2, 2023, 2:30 pm

Rising prevalence of hiv & contagious diseases to drive sales of blotting systems; market is predicted to expand at a cagr of 5%: fact.mr analysis

Blotting Systems Are Heavily Utilized By Biotech And pharmaceutical Companies For The Discovery Of New ...

January 2, 2023, 11:30 am

Scpharmaceuticals, inc. (scph) is a great choice for 'trend' investors, here's why

scpharmaceuticals, Inc. (SCPH) could be a great choice for investors looking to make a profit from fund...

January 2, 2023, 10:32 am

2023 a big year for testosterone: abbvie and ani pharmaceuticals best positioned to benefit

Results from three major testosterone trials expected in 2023, including the largest testosterone cardiovascular safety/efficacy trials for men and wo...

January 1, 2023, 8:29 am

Rosen, a leading and longstanding firm, encourages eiger biopharmaceuticals, inc. investors to secure counsel before important january 9 deadline in securities class action – eigr

WHY: NEW YORK, Dec. 31, 2022 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...

December 31, 2022, 8:03 pm

: kala pharmaceuticals stock up 750% in 3 days after upbeat fda news on pced treatment

Shares of Kala pharmaceuticals Inc. KALA have rocketed higher in for three-straight sessions, toward a ...

December 30, 2022, 5:02 pm

Rvl pharmaceuticals: a first 'look'

Today we take our first look at RVL pharmaceuticals plc, a small ocular-focused concern. RVL ...

December 30, 2022, 3:30 pm

5 stocks that outperformed the s&p 500 in 2022

According to the All-in-one Screener, a Premium feature of GuruFocus, five stocks that outperformed the Standard & Poor's 500 index in 2022 yet are mo...

December 30, 2022, 3:06 pm

Rigel pharmaceuticals: a strong finish to 2022 and a potentially transformative 2023

In terms of product sales, RIGL has been a one drug company with Tavalisse in immune thrombocytopenia. The recent approval of Rezlidhia opens the door...

December 30, 2022, 2:44 pm

Palisade bio announces $2.5 million registered direct offering and concurrent private placement priced above market under nasdaq rules

Carlsbad, CA, Dec. 30, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharma...

December 30, 2022, 1:45 pm

Kala pharmaceuticals stock up 750% in 3 days after upbeat fda news on pced treatment

Shares of Kala pharmaceuticals Inc. KALA, +39.53% have rocketed higher in for three-straight sessions, ...

December 30, 2022, 12:02 pm

Lidding films market size to surpass usd 6.7 billion by 2028 at 5% cagr – report by market research future (mrfr)

Lidding Films Market Insights and Industry Analysis By Product (Dual-Ovenable Lidding Films, Specialty Lidding Films, High Barrier Lidding Films and O...

December 30, 2022, 9:30 am

Okyo pharma eyes progress for ok-101 in 2023, releases interim results

OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO) has released its interim results for the six months ended 30 September 2022, a period in which its primary foc...

December 30, 2022, 4:48 am

Disc medicine announces completion of merger with gemini therapeutics

The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol “IRON” Approximately $175 mi...

December 29, 2022, 10:15 pm

Tech. analyst says pharma co. is at a favorable risk/reward ratio

Source: Clive Maund (12/28/22) Technical analyst Clive Maund reviews Algernon pharmaceuticals Inc.’s ...

December 29, 2022, 5:44 pm

Ardelyx: the journey continues

Shares of biopharmaceutical concern Ardelyx, Inc. have fallen over 60% since the FDA initially rejected...

December 29, 2022, 4:01 pm

Global algae products market is expected to be at worth of us$ 5.41 bn in 2023 and likely to cross a revenue of us$ 9.15 bn at a cagr of 5.4% by year 2033-end | data by future market insights, inc. ex

Consumer Awareness of Algae Products and Health benefits of Omega-3 to Surge the Demand: Explore the Latest Research Report by FMI. Increased Use of A...

December 29, 2022, 10:30 am

Kala pharmaceuticals stock continues to soar: what's going on? - kala pharmaceuticals (nasdaq:kala)

Kala pharmaceuticals Inc KALA shares are trading higher Thursday. The stock appears to be moving on co...

December 29, 2022, 8:30 am

Ardelyx stock rises as fda grants appeal for new drug application for xphozah

Ardelyx Inc. ARDX, +5.02% stock is up 5.2% in premarket trades on Thursday after the Waltham, Mass., biopharma...

December 29, 2022, 7:21 am

Class action involving spectrum pharmaceuticals, inc. (sppi): contact robbins llp if you incurred significant financial harm from your investment in spectrum pharmaceuticals, inc.

SAN DIEGO, Dec. 28, 2022 (GLOBE NEWSWIRE) — The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purcha...

December 28, 2022, 10:18 pm


Search within

Pages Search Results: